デフォルト表紙
市場調査レポート
商品コード
1427943

市販薬と栄養補助食品の世界市場レポート 2024年

OTC Drug And Dietary Supplement Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
市販薬と栄養補助食品の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

市販薬と栄養補助食品の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.2%の年間複合成長率(CAGR)で4,389億3,000万米ドルに成長すると予想されます。予測期間で予想される成長は、個別化された栄養とサプリメントの出現、栄養補助食品分野の革新、機能性食品市場の拡大、世界の健康への懸念とその備えの高まり、健康を促進する政府の取り組みなど、さまざまな要因によるものです。予測期間中に予想される主要動向には、製品革新、クリーンラベルと天然成分への重点、カンナビジオール(CBD)と麻ベースの製品の組み込み、持続可能で環境に優しい包装慣行の採用、社内でのパートナーシップとコラボレーションの増加が含まれます。業界。これらの動向は、次期の成長を形成し、推進する態勢が整っています。

予想される医薬品の研究開発(R&D)支出の増加により、今後数年間で市販薬と栄養補助食品市場が大幅に拡大すると見込まれています。研究開発投資は、製品の開発、設計、強化のために企業が負担する費用を含み、市販薬や栄養補助食品の製剤化における革新と生産性を促進すると期待されています。注目すべきことに、2021年に発行された欧州製薬産業協会連合の報告書によると、欧州の医療産業は研究開発費に約415億ユーロ(444億7,000万米ドル)を投資し、2020年の396億5,000万ユーロ(424億9,000万米ドル)からの増加を反映しています。医薬品の研究開発支出の急増は、市販薬と栄養補助食品市場の成長の原動力となっています。

栄養補助食品に対する需要の高まりにより、市販薬と栄養補助食品市場の拡大がさらに促進されることになります。栄養補助食品、ミネラル、ハーブ、アミノ酸、または食事を補うことを目的としたその他の栄養成分を含む製品で構成される栄養補助食品は、処方箋なしで販売できる市販ステータスを享受しています。このアクセシビリティは、薬局、スーパーマーケット、オンラインプラットフォームなどのさまざまな小売店を通じて強化され、消費者の選択を容易にし、市場の成長に貢献します。たとえば、責任ある栄養評議会が2021年に実施した栄養補助食品に関するCRN消費者調査では、アメリカ人の5人中4人が栄養補助食品を使用しており、そのようなサプリメントを使用するアメリカ人の数は80%増加すると予想されていることが明らかになりました。したがって、栄養補助食品の需要の増加は、市販薬と栄養補助食品市場の成長の重要な推進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市販薬と栄養補助食品市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市販薬と栄養補助食品の市場規模実績と成長、2018~2023年
  • 世界の市販薬と栄養補助食品市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の市販薬と栄養補助食品市場、カテゴリー別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • ビタミンと栄養補助食品
  • 咳止めと風邪製品
  • 鎮痛剤
  • 胃腸薬
  • 睡眠補助薬
  • 耳用製品
  • イボ除去剤
  • マウスケア製品
  • 眼科用製品
  • その他
  • 世界の市販薬と栄養補助食品市場、剤形別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • タブレット
  • ハードカプセル
  • 粉末
  • 軟膏
  • ソフトカプセル
  • 液体
  • その他
  • 世界の市販薬と栄養補助食品市場、用途別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 薬局
  • 食料品店
  • ビタミンと健康食品の店
  • オンライン薬局

第7章 地域と国の分析

  • 世界の市販薬と栄養補助食品市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の市販薬と栄養補助食品市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 市販薬と栄養補助食品市場の競合情勢
  • 市販薬と栄養補助食品市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson Ltd.
    • F. Hoffmann-La Roche AG
    • Merck &Co. Inc.
    • AbbVie Inc.

第31章 その他の大手と革新的な企業

  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • AstraZeneca plc
  • Abbott Laboratories Inc
  • GSK plc
  • Gilead Sciences Inc.
  • Reckitt Benckiser Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Church &Dwight Co Inc
  • Perrigo Company plc
  • Dr. Reddy's Laboratories Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r13787

Over-the-counter (OTC) drugs encompass pharmaceuticals readily available without prescription, addressing common medical conditions. Conversely, dietary supplements are formulated to augment specific nutrients or bioactive compounds in one's diet, intended for health enhancement rather than disease treatment, prevention, or cure.

The primary categories within OTC drugs and dietary supplements include vitamin and dietary supplements, cough and cold products, analgesics, gastrointestinal products, sleep aids, otic products, wart removers, mouth care products, ophthalmic products, and others. Vitamin and dietary supplements consist of chemical substances utilized in minimal quantities for diverse metabolic processes, contributing to overall health and aiding in the management of various health issues. These products are accessible in various forms such as tablets, hard capsules, powders, ointments, soft capsules, liquids, and more, and are conveniently found in pharmacies, grocery stores, vitamin and health food stores, as well as online pharmacies.

The OTC drug and dietary supplement market research report is one of a series of new reports from The Business Research Company that provides OTC drug and dietary supplement market statistics, including OTC drug and dietary supplement industry global market size, regional shares, competitors with an OTC drug and dietary supplement market share, detailed OTC drug and dietary supplement market segments, market trends and opportunities, and any further data you may need to thrive in the OTC drug and dietary supplement industry. This OTC drug and dietary supplement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The otc drug and dietary supplement market size has grown strongly in recent years. It will grow from $310.97 billion in 2023 to $331.84 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. During the historical period, the notable growth can be ascribed to several key factors. These include a rise in the number of fitness enthusiasts, demographic shifts marked by an aging population, regulatory approvals and adherence to safety standards, expansions in pharmacy and retail sectors, and effective marketing and advertising strategies. These combined elements have contributed significantly to the growth observed in this timeframe.

The otc drug and dietary supplement market size is expected to see strong growth in the next few years. It will grow to $438.93 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The anticipated growth in the forecast period is attributable to various factors, including the emergence of personalized nutrition and supplements, innovations in the nutraceutical sector, the expanding market for functional foods, heightened global health concerns and preparedness, as well as governmental initiatives promoting wellness. Key trends expected in the forecast period encompass product innovations, a focus on clean label and natural ingredients, the incorporation of cannabidiol (CBD) and hemp-based products, the adoption of sustainable and eco-friendly packaging practices, and increased partnerships and collaborations within the industry. These trends are poised to shape and drive growth in the upcoming period.

The anticipated rise in pharmaceutical Research and Development (R&D) expenditure is poised to significantly boost the OTC drug and dietary supplement market in the coming years. R&D investment, encompassing expenses incurred by companies for the development, design, and enhancement of their offerings, is expected to foster innovation and productivity in the formulation of OTC drugs and dietary supplements. Notably, according to a report from the European Federation of Pharmaceutical Industries and Associations published in 2021, European health industries invested approximately 41.5 billion euros ($44.47 billion) in R&D expenditure, reflecting an increase from 39.65 billion euros ($42.49 billion) in 2020. This surge in pharmaceutical R&D expenditure serves as a driving force behind the growth of the OTC drug and dietary supplement market.

The escalating demand for dietary supplements is set to further propel the expansion of the OTC drug and dietary supplement market. Dietary supplements, comprising products containing vitamins, minerals, herbs, amino acids, or other dietary ingredients aimed at supplementing one's diet, enjoy OTC status, allowing them to be sold without a prescription. This accessibility is heightened through various retail outlets such as pharmacies, supermarkets, and online platforms, facilitating consumer choice and contributing to market growth. For instance, the CRN Consumer Survey on Dietary Supplements conducted by the Council for Responsible Nutrition in 2021 revealed that four out of five Americans were using dietary supplements, with an expected 80% increase in the number of Americans using such supplements. Hence, the increasing demand for dietary supplements stands as a significant driver for the growth of the OTC drug and dietary supplement market.

The OTC drug and dietary supplement market is experiencing a significant trend towards product innovation, with major companies actively developing novel products to enhance their market positions. An example of this trend is evident in the actions of Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical industry player. In July 2022, the company introduced over-the-counter (OTC) Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg extended-release tablets. This OTC product serves as both an oral antihistamine and nasal decongestant, offering temporary relief for nasal and sinus congestion caused by colds or allergies. The launch of such innovative products contributes to the expansion of OTC portfolios, addressing specific health needs.

Major companies are strategically focusing on groundbreaking innovations, such as the development of oral contraceptive pills (OCP), to fortify their market presence. Perrigo Company PLC, an Ireland-based self-care company, achieved a noteworthy milestone in July 2023 when the U.S. Food and Drug Administration (FDA) granted approval for Opill, a progestin-only daily oral contraceptive, to be available over-the-counter (OTC) for all ages. This landmark decision marked Opill as the first-ever OTC accessible birth control pill in the United States. Perrigo's CEO, Patrick Lockwood-Taylor, emphasized the historical significance of this development for women's health, highlighting Opill's potential to revolutionize access to contraception. The approval underscores Perrigo's commitment to impactful solutions that enhance lives, representing a significant advancement in women's health.

In June 2022, Glenmark Pharmaceuticals Ltd., an India-based biopharmaceutical company, bolstered its presence in the OTC market in the United States by acquiring specific over-the-counter approved generic versions of drugs from Wockhardt Ltd. This undisclosed acquisition from Wockhardt Ltd., an India-based pharmaceutical and biotechnology company, further positions Glenmark Pharmaceuticals in the competitive OTC drug and dietary supplement market, demonstrating a commitment to expansion and strategic growth initiatives.

Major companies operating in the otc drug and dietary supplement market report are Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, AstraZeneca PLC, Abbott Laboratories Inc., GSK PLC, Gilead Sciences Inc., Reckitt Benckiser Plc., Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Church & Dwight Co Inc., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Cipla Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Ltd., Nutraceutical International Corporation, Procter & Gamble Health Limited, Reese Pharmaceutical Company, UPM Pharmaceuticals Inc., Gemini Pharmaceuticals Inc., Pharmavite LLC, Now Health Group Inc., Alfresa Pharma Corporation

North America was the largest region in the OTC drug and dietary supplement market in 2023. The regions covered in the otc drug and dietary supplement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the otc drug and dietary supplement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The OTC drug and dietary supplement market consist of sales of pain relievers, omega-3 fatty acids, probiotics, and herbal supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

OTC Drug And Dietary Supplement Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on otc drug and dietary supplement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for otc drug and dietary supplement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The otc drug and dietary supplement market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Category: Vitamin And Dietary Supplements; Cough And Cold Products; Analgesics; Gastrointestinal Products; Sleep Aids; Otic Products; Wart Removers; Mouth Care Products; Ophthalmic Products; Other Categories
  • 2) By Dosage Form: Tablets; Hard Capsules; Powders; Ointments; Soft Capsules; Liquids; Other Dosage Forms
  • 3) By Application: Pharmacies; Grocery Stores; Vitamin And Health Food Stores; Online Pharmacies
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Ltd.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. OTC Drug And Dietary Supplement Market Characteristics

3. OTC Drug And Dietary Supplement Market Trends And Strategies

4. OTC Drug And Dietary Supplement Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global OTC Drug And Dietary Supplement Market Size and Growth

  • 5.1. Global OTC Drug And Dietary Supplement Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global OTC Drug And Dietary Supplement Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global OTC Drug And Dietary Supplement Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. OTC Drug And Dietary Supplement Market Segmentation

  • 6.1. Global OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Vitamin And Dietary Supplements
  • Cough And Cold Products
  • Analgesics
  • Gastrointestinal Products
  • Sleep Aids
  • Otic Products
  • Wart Removers
  • Mouth Care Products
  • Ophthalmic Products
  • Other Categories
  • 6.2. Global OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Tablets
  • Hard Capsules
  • Powders
  • Ointments
  • Soft Capsules
  • Liquids
  • Other Dosage Forms
  • 6.3. Global OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmacies
  • Grocery Stores
  • Vitamin And Health Food Stores
  • Online Pharmacies

7. OTC Drug And Dietary Supplement Market Regional And Country Analysis

  • 7.1. Global OTC Drug And Dietary Supplement Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global OTC Drug And Dietary Supplement Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific OTC Drug And Dietary Supplement Market

  • 8.1. Asia-Pacific OTC Drug And Dietary Supplement Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China OTC Drug And Dietary Supplement Market

  • 9.1. China OTC Drug And Dietary Supplement Market Overview
  • 9.2. China OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India OTC Drug And Dietary Supplement Market

  • 10.1. India OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan OTC Drug And Dietary Supplement Market

  • 11.1. Japan OTC Drug And Dietary Supplement Market Overview
  • 11.2. Japan OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia OTC Drug And Dietary Supplement Market

  • 12.1. Australia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia OTC Drug And Dietary Supplement Market

  • 13.1. Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea OTC Drug And Dietary Supplement Market

  • 14.1. South Korea OTC Drug And Dietary Supplement Market Overview
  • 14.2. South Korea OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe OTC Drug And Dietary Supplement Market

  • 15.1. Western Europe OTC Drug And Dietary Supplement Market Overview
  • 15.2. Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK OTC Drug And Dietary Supplement Market

  • 16.1. UK OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany OTC Drug And Dietary Supplement Market

  • 17.1. Germany OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France OTC Drug And Dietary Supplement Market

  • 18.1. France OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy OTC Drug And Dietary Supplement Market

  • 19.1. Italy OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain OTC Drug And Dietary Supplement Market

  • 20.1. Spain OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe OTC Drug And Dietary Supplement Market

  • 21.1. Eastern Europe OTC Drug And Dietary Supplement Market Overview
  • 21.2. Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia OTC Drug And Dietary Supplement Market

  • 22.1. Russia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America OTC Drug And Dietary Supplement Market

  • 23.1. North America OTC Drug And Dietary Supplement Market Overview
  • 23.2. North America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA OTC Drug And Dietary Supplement Market

  • 24.1. USA OTC Drug And Dietary Supplement Market Overview
  • 24.2. USA OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada OTC Drug And Dietary Supplement Market

  • 25.1. Canada OTC Drug And Dietary Supplement Market Overview
  • 25.2. Canada OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America OTC Drug And Dietary Supplement Market

  • 26.1. South America OTC Drug And Dietary Supplement Market Overview
  • 26.2. South America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil OTC Drug And Dietary Supplement Market

  • 27.1. Brazil OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East OTC Drug And Dietary Supplement Market

  • 28.1. Middle East OTC Drug And Dietary Supplement Market Overview
  • 28.2. Middle East OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa OTC Drug And Dietary Supplement Market

  • 29.1. Africa OTC Drug And Dietary Supplement Market Overview
  • 29.2. Africa OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. OTC Drug And Dietary Supplement Market Competitive Landscape And Company Profiles

  • 30.1. OTC Drug And Dietary Supplement Market Competitive Landscape
  • 30.2. OTC Drug And Dietary Supplement Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck & Co. Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. OTC Drug And Dietary Supplement Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Novartis AG
  • 31.3. Sanofi S.A
  • 31.4. AstraZeneca plc
  • 31.5. Abbott Laboratories Inc
  • 31.6. GSK plc
  • 31.7. Gilead Sciences Inc.
  • 31.8. Reckitt Benckiser Plc.
  • 31.9. Teva Pharmaceutical Industries Ltd.
  • 31.10. Alcon Inc.
  • 31.11. Bausch Health Companies Inc.
  • 31.12. Sun Pharmaceutical Industries Ltd.
  • 31.13. Church & Dwight Co Inc
  • 31.14. Perrigo Company plc
  • 31.15. Dr. Reddy's Laboratories Ltd.

32. Global OTC Drug And Dietary Supplement Market Competitive Benchmarking

33. Global OTC Drug And Dietary Supplement Market Competitive Dashboard

34. Key Mergers And Acquisitions In The OTC Drug And Dietary Supplement Market

35. OTC Drug And Dietary Supplement Market Future Outlook and Potential Analysis

  • 35.1 OTC Drug And Dietary Supplement Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 OTC Drug And Dietary Supplement Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 OTC Drug And Dietary Supplement Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer